Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07530653

Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries.

This study will provide information on the quality of care in hemorrhagic shock of severe injuries in a limited resource facility of Latin America, the strategies of fluid resuscitation, and outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Departamental de Villavicencio

Villavicencio, Meta Department, 50001, Colombia

Location contact

Emma Rodriguez Darabos, MSc

CONTACT

[email protected]

Norton Perez, MD

CONTACT

[email protected]

3112517471

Norton Perez, MD

PRINCIPAL_INVESTIGATOR

About this study

Background / Introduction

Trauma remains a leading cause of mortality worldwide, particularly among young and economically productive populations, generating a disproportionate burden in terms of years of life lost, disability, and healthcare expenditures. Hemorrhagic shock is the most common cause of preventable death following trauma, especially within the first hours after injury. Despite advances in trauma systems and critical care, early mortality due to uncontrolled bleeding continues to pose a major clinical challenge.

Traditional resuscitation strategies have emphasized aggressive early fluid administration aimed at restoring normotension. However, growing evidence suggests that this approach may be physiologically detrimental in the setting of uncontrolled hemorrhage. Rapid volume expansion can dislodge forming clots, dilute coagulation factors, exacerbate acidosis, and contribute to the development of trauma-induced coagulopathy. These mechanisms are closely associated with the so-called "lethal triad" of trauma: hypothermia, acidosis, and coagulopathy, which significantly increases mortality risk.

In response to these concerns, the concept of delayed resuscitation, also referred to as permissive hypotension, has emerged as a damage control strategy. This approach aims to limit fluid administration until hemorrhage control is achieved, maintaining a lower-than-normal blood pressure sufficient for minimal organ perfusion while avoiding exacerbation of bleeding. Experimental models and clinical studies have suggested potential benefits, including reduced blood loss, lower transfusion requirements, and improved survival in selected patient populations.

However, the current body of evidence presents important limitations. Many studies have been conducted in high-resource settings with well-developed trauma systems, rapid surgical access, and availability of blood products. Furthermore, heterogeneity in study design, patient populations, injury patterns, and resuscitation protocols limits the generalizability of findings. Importantly, patients with traumatic brain injury, elderly individuals, and those with significant comorbidities may respond differently to hypotensive strategies, raising concerns regarding safety and applicability.

These uncertainties are particularly relevant in low- and middle-income countries (LMICs), including those in Latin America, where the burden of trauma is disproportionately high and healthcare systems often face resource constraints. In such settings, delays in definitive hemorrhage control, limited access to blood products, variability in prehospital care, and constrained intensive care capacity may influence both the feasibility and effectiveness of resuscitation strategies. Consequently, there is a critical need for context-specific evidence to guide clinical decision-making and optimize trauma care protocols in these environments.

Objective

To compare clinical outcomes in patients with hemorrhagic shock due to severe trauma according to the initial fluid resuscitation strategy, specifically delayed (permissive hypotension) versus immediate (conventional) resuscitation, in low-resource healthcare settings in Latin America.

Methods Study Design

This study is designed as a prospective, observational, analytical cohort study conducted in one or more tertiary-level trauma centers in Latin America. The study will adhere to STROBE guidelines for observational research.

Study Population

Eligible participants will include adult patients (≥18 years) presenting with severe trauma and clinical evidence of hemorrhagic shock. Hemorrhagic shock will be defined using a combination of clinical and laboratory criteria, including systolic blood pressure <90 mmHg, elevated lactate levels, base deficit, and/or clinical signs of hypoperfusion.

Inclusion criteria

Adult patients with major trauma (Injury Severity Score ≥15) Evidence of active bleeding or suspected hemorrhagic shock Admission within a defined time window from injury Exclusion Criteria Severe traumatic brain injury requiring strict blood pressure targets Cardiac arrest prior to hospital arrival Pregnant patients Patients with advanced directives limiting care Exposure Definition

Patients will be categorized based on the initial resuscitation strategy:

Delayed resuscitation group: restricted fluid administration prior to hemorrhage control, targeting permissive hypotension (e.g., systolic blood pressure 80-90 mmHg or presence of radial pulse) Immediate resuscitation group: standard aggressive fluid resuscitation aiming to restore normotension Data Collection

Data will be collected prospectively using standardized case report forms and will include:

Demographic characteristics Mechanism and severity of injury Prehospital and emergency department interventions Hemodynamic parameters and laboratory values Volume of fluids and blood products administered Time to hemorrhage control Outcomes Primary Outcome In-hospital mortality Secondary Outcomes 24-hour mortality Blood product utilization Development of complications (e.g., acute respiratory distress syndrome, multiple organ dysfunction syndrome, acute kidney injury) Length of stay in intensive care unit and hospital Need for surgical or interventional procedures Statistical Analysis

Descriptive statistics will be used to summarize baseline characteristics. Comparisons between groups will be performed using appropriate statistical tests (Chi-square, t-test, or Mann-Whitney U test). Multivariable logistic regression models will be constructed to evaluate the association between resuscitation strategy and outcomes, adjusting for potential confounders such as injury severity, age, mechanism of trauma, and comorbidities.

Propensity score methods may be employed to reduce selection bias and improve comparability between groups. Sensitivity analyses will be conducted to assess robustness of findings.

Expected Results

It is hypothesized that delayed resuscitation will be associated with:

Reduced in-hospital mortality Lower transfusion requirements Decreased incidence of complications related to fluid overload and coagulopathy

However, potential risks, including inadequate organ perfusion and adverse outcomes in specific subgroups, will also be critically evaluated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major injuries.
  • ISS >15.
  • Hypotension with a systolic blood pressure below 90 mmHg.
  • No previous hospital care.
  • Older than 16 years.

Exclusion criteria

  • Brain injuries.
  • Pregnancy.
  • Drowning.
  • Burns.

Treatment and study plan

Crystalloid below 1000 mL.

Drug

Administration of IV fluids below 1,000 mL on prehospital care.

Other names: Restricted IV fluids, Permissive hypotension

IV fluids more than 1,000 mL

Drug

Prehospital IV fluids more than 1,000 mL.

Other names: High volume resuscitation

Primary outcomes

  1. In-hospital mortality

    Time frame: 28 days

    Mortality on discharge or before 28 days.

Secondary outcomes

  1. Early mortality

    Time frame: 24 hours.

    Mortality in the ICU or within 24 hours of admission.

  2. Coagulopathy

    Time frame: 24 hours.

    Bleeding times prolonged > 1.5 times.

Study contacts

Contact information is provided by the study sponsor or research team.

Emma I Rodriguez Darabos, MSc

CONTACT

[email protected]

3112517538

Norton Perez, MD

CONTACT

[email protected]

+573112517471

Sponsors and collaborators

Lead sponsor

Hospital Departamental de Villavicencio

Other

Registry information

Official study title

Delayed Resuscitation in Hemorrhagic Shock Due to Severe Injuries of the Torso in Low-resource Facilities of Latin America.

Acronym: PERMIT-LATAM

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Apr 15, 2026
Registry last updated
May 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.